Public Company News
HD Hyundai Vice Chairman Chung Kisun Promoted to Chairman
SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ -- HD Hyundai announced that
Executive Vice ChairmanChung Kisun has been promoted to Chairman in its latest
executive appointments.
2025-10-20 14:24
1941
Zeekr Group to Report Third Quarter 2025 Financial Results on November 17, 2025
HANGZHOU, China, Oct. 20, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced that it will report its unaudited financial results for the third quarter endedSeptember 3...
2025-10-20 13:00
1727
CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025
SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational clinical trial of satricabtagene autoleucel ("satri-cel", CT041)...
2025-10-20 08:15
2550
ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)
SUZHOU, China, Oct. 19, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced the first disclosure...
2025-10-20 08:10
1825
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.
2025-10-20 07:00
1404
Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025
HONG KONG, Oct. 19, 2025 /PRNewswire/ -- On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) . COMPASSION-15 is a Phase III clinical trial evaluating cadonilimab, Ak...
2025-10-19 23:42
1830
HARMONi-6 Data: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet
* Ivonescimab plus chemotherapy demonstrated a median PFS of 11.14 months, PFS HR=0.60, P < 0.0001. * The absolute difference in median PFS between the two groups was 4.24 months (ΔPFS = 4.24 months), indicating significantly prolonged progression-free survival with ivonescimab combination th...
2025-10-19 23:37
1652
Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and conventional therapies for multiple myeloma are typically...
2025-10-19 14:00
1960
PINTEC's Subsidiary ZIITECH Makes Its Debut at Tech Week Singapore 2025
BEIJING, Oct. 17, 2025 /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("PINTEC" or the "Company"), a leading technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that its subsidiary ZIITECH PTY LTD ("ZIITEC...
2025-10-18 04:05
3556
CLPS Incorporation Reports Financial Results for the Second Half and Full Year of Fiscal 2025
HONG KONG, Oct. 17, 2025 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced its financial results for the six months and full year of fiscal 2025 ended June 30, 2025. During this fiscal year, we faced a significant challenge when our long-standing and hi...
2025-10-17 21:23
4315
SparkRWA Expands AI Applications to Empower the Global Green Economy and Drive Sustainable Innovation
HONG KONG, Oct. 17, 2025 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), Asia's leading innovation-driven creative ecosystem, today announced an extended application of its proprietary AI technologies under theSparkRWA Green Creator Framework, marking a major step toward integrating artificial...
2025-10-17 20:43
2433
Re-imagining Neo-Pragmatic Lifestyle: EPWK Launches Strategic Upgrade with "EPWK Curated Goods"
XIAMEN, China, Oct. 17, 2025 /PRNewswire/ -- "We grew weary of life's monotony, so we embarked on a journey to find 'EPWK Curated Goods.' Each selected item must pass our stringent 'Three Goods' standard: Good-looking, Good-to-use, and Good-surprise. We believe that truly excellent products can i...
2025-10-17 20:36
1630
Erayak Power Solution Group Inc. Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy
WENZHOU, China, Oct. 17, 2025 /PRNewswire/ -- Erayak Power Solution Group Inc. ("Erayak" or the "Company") (Nasdaq: RAYA), a leading manufacturer and exporter of advanced power solution products, today announced the establishment of its U.S. subsidiary, Nexora Group Inc., marking a strategic mile...
2025-10-17 18:16
2511
SEMIFIVE Submits Securities Registration for KOSDAQ Listing
* Secures Only 'One-Stop AI ASIC Solution' in Korea and Big-Die Design Capability * 2025 Q3 Cumulative Revenue Expected to Surpass KRW 90 Billion; Large AI Chip Mass Production Begins, Growth to Accelerate from Q4 * Wins Successive AI Chip Design Projects for Global Customers, Expanding int...
2025-10-17 17:25
2008
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. TO HOLD ANNUAL GENERAL MEETING ON NOVEMBER 21, 2025
BEIJING, Oct. 17, 2025 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU and SEHK: 9901), a provider of private educational services inChina, today announced that it will hold an annual general meeting (the "AGM") of shareholders (the "Not...
2025-10-17 17:00
1856
FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States
* YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications – adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the U.S.[1],[2] * Pediatric UV is a rare eye inflammation in children, representing 5–10% of all uveitis...
2025-10-17 13:32
2656
Compal Showcases Comprehensive Data Center Solutions at 2025 OCP Global Summit; Unveils SGX30-2 High-Performance AI Server Built with NVIDIA HGX™ B300
SAN JOSE, Calif., Oct. 16, 2025 /PRNewswire/ -- Global data centers are facing new challenges driven by AI – greater compute demand, larger working sets, and more stringent energy efficiency requirements. At this year's OCP Global Summit, Compal Electronics (Compal; Ticker: 2324.TW) presented a c...
2025-10-17 00:00
1623
Clarity signs copper-67 Supply Agreement with Nusano
SYDNEY, Oct. 16, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supp...
2025-10-16 21:04
2955
Hyundai Mobis wins awards at three global advertising festivals with 'Move Improved' campaign
* Selected as a finalist in the 'Corporate Online Media – Social Media Videos' category at the 16th Cannes Corporate Media & TV Awards... the only Korean company in the list * Also won top prizes at North American global advertising festivals '2025 Muse Creative Award' and '2025 NYX Award' ...
2025-10-16 20:00
2221
Canadian Solar Schedules Third Quarter 2025 Earnings Conference Call for November 13
KITCHENER, ON, Oct. 16, 2025 /PRNewswire/ -- Canadian Solar Inc
2025-10-16 19:00
1419
Week's Top Stories
Most Reposted
Visa partners with Laufey to spread the magic of travel in Asia Pacific; to be Official Payment Partner for Laufey: A Matter of Time Tour
[Picked up by 309 media titles]
2026-03-04 12:35
SMU and Fudan Launch Region's First Tech-Focused DBA
[Picked up by 300 media titles]
2026-03-02 09:15Klook's Spring Readiness Index shows how Asia's travelers are preparing for spring travel across Japan, South Korea, and Mainland China
[Picked up by 290 media titles]
2026-03-03 15:49
Infobip is set to launch AgentOS to orchestrate autonomous AI-driven customer journeys at scale
[Picked up by 290 media titles]
2026-03-02 09:00
COL and NASDAQ-Listed BeLive Holdings Unveil World's First "Microdrama in a Box" in Headline Hong Kong FILMART 2026 Launch
[Picked up by 287 media titles]
2026-03-05 17:14
Most Read
COLUMBIA ASIA HOSPITAL BUKIT JALIL LAUNCHES NEW CATH LAB TO STRENGTHEN HEART CARE SERVICES
2026-03-02 14:24
10190
